| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prostaglandin-endoperoxide synthase activity | 1.50e-06 | 2 | 25 | 2 | GO:0004666 | |
| GeneOntologyMolecularFunction | peroxidase activity | 7.19e-05 | 65 | 25 | 3 | GO:0004601 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on peroxide as acceptor | 7.88e-05 | 67 | 25 | 3 | GO:0016684 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.70e-04 | 431 | 25 | 5 | GO:0004984 | |
| GeneOntologyMolecularFunction | antioxidant activity | 2.36e-04 | 97 | 25 | 3 | GO:0016209 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 4.44e-04 | 25 | 25 | 2 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 4.80e-04 | 26 | 25 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 6.35e-04 | 884 | 25 | 6 | GO:0004930 | |
| GeneOntologyMolecularFunction | heme binding | 9.13e-04 | 154 | 25 | 3 | GO:0020037 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.05e-03 | 1353 | 25 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.10e-03 | 164 | 25 | 3 | GO:0046906 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 6.65e-03 | 98 | 25 | 2 | GO:0051213 | |
| GeneOntologyBiologicalProcess | cyclooxygenase pathway | 7.71e-05 | 11 | 25 | 2 | GO:0019371 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 9.61e-05 | 202 | 25 | 4 | GO:0006937 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 1.17e-04 | 79 | 25 | 3 | GO:0006940 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 1.48e-04 | 432 | 25 | 5 | GO:0050911 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 2.09e-04 | 465 | 25 | 5 | GO:0007608 | |
| GeneOntologyBiologicalProcess | cellular oxidant detoxification | 2.35e-04 | 100 | 25 | 3 | GO:0098869 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 2.53e-04 | 485 | 25 | 5 | GO:0050907 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 3.62e-04 | 524 | 25 | 5 | GO:0009593 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 4.41e-04 | 547 | 25 | 5 | GO:0007606 | |
| GeneOntologyBiologicalProcess | cellular detoxification | 4.75e-04 | 127 | 25 | 3 | GO:1990748 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 5.37e-04 | 317 | 25 | 4 | GO:0090257 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 5.43e-04 | 133 | 25 | 3 | GO:0006939 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell differentiation | 5.61e-04 | 29 | 25 | 2 | GO:0090335 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 5.85e-04 | 582 | 25 | 5 | GO:0050906 | |
| GeneOntologyBiologicalProcess | cellular response to toxic substance | 6.18e-04 | 139 | 25 | 3 | GO:0097237 | |
| GeneOntologyBiologicalProcess | prostaglandin biosynthetic process | 8.66e-04 | 36 | 25 | 2 | GO:0001516 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle contraction | 8.66e-04 | 36 | 25 | 2 | GO:0045987 | |
| GeneOntologyBiologicalProcess | prostanoid biosynthetic process | 8.66e-04 | 36 | 25 | 2 | GO:0046457 | |
| GeneOntologyBiologicalProcess | detoxification | 1.11e-03 | 170 | 25 | 3 | GO:0098754 | |
| GeneOntologyBiologicalProcess | maintenance of blood-brain barrier | 1.18e-03 | 42 | 25 | 2 | GO:0035633 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.28e-03 | 400 | 25 | 4 | GO:0006936 | |
| MousePheno | decreased urine prostaglandin level | 3.68e-06 | 3 | 16 | 2 | MP:0011564 | |
| MousePheno | abnormal urine prostaglandin level | 1.23e-05 | 5 | 16 | 2 | MP:0011562 | |
| MousePheno | disorganized secondary lens fibers | 8.05e-05 | 12 | 16 | 2 | MP:0002579 | |
| MousePheno | increased prostaglandin level | 9.51e-05 | 13 | 16 | 2 | MP:0009814 | |
| MousePheno | decreased prostaglandin level | 9.51e-05 | 13 | 16 | 2 | MP:0009815 | |
| MousePheno | allodynia | 1.28e-04 | 15 | 16 | 2 | MP:0003177 | |
| MousePheno | abnormal stomach pH | 2.08e-04 | 19 | 16 | 2 | MP:0008004 | |
| MousePheno | abnormal response of heart to induced stress | 2.40e-04 | 109 | 16 | 3 | MP:0004484 | |
| MousePheno | abnormal renal glomerular filtration rate | 3.63e-04 | 25 | 16 | 2 | MP:0002847 | |
| MousePheno | abnormal prostaglandin level | 3.93e-04 | 26 | 16 | 2 | MP:0009811 | |
| MousePheno | increased susceptibility to weight gain | 4.12e-04 | 131 | 16 | 3 | MP:0005455 | |
| MousePheno | increased susceptibility to age related obesity | 4.24e-04 | 27 | 16 | 2 | MP:0003212 | |
| MousePheno | abnormal renal glomerular filtration | 4.90e-04 | 29 | 16 | 2 | MP:0013284 | |
| MousePheno | decreased susceptibility to induced thrombosis | 5.24e-04 | 30 | 16 | 2 | MP:0031120 | |
| MousePheno | abnormal keratinocyte differentiation | 5.24e-04 | 30 | 16 | 2 | MP:0002656 | |
| MousePheno | increased epididymal fat pad weight | 5.97e-04 | 32 | 16 | 2 | MP:0009288 | |
| MousePheno | abnormal parturition | 6.35e-04 | 33 | 16 | 2 | MP:0002907 | |
| MousePheno | abnormal uterine environment | 7.15e-04 | 35 | 16 | 2 | MP:0004014 | |
| MousePheno | decreased susceptibility to autoimmune disorder | 1.04e-03 | 180 | 16 | 3 | MP:0005351 | |
| MousePheno | abnormal nociception after inflammation | 1.13e-03 | 44 | 16 | 2 | MP:0002736 | |
| MousePheno | enlarged cecum | 1.29e-03 | 47 | 16 | 2 | MP:0009476 | |
| MousePheno | abnormal lens fiber morphology | 1.40e-03 | 49 | 16 | 2 | MP:0002840 | |
| Domain | PEROXIDASE_3 | 2.53e-07 | 10 | 25 | 3 | PS50292 | |
| Domain | Haem_peroxidase | 2.53e-07 | 10 | 25 | 3 | IPR010255 | |
| Domain | - | 2.53e-07 | 10 | 25 | 3 | 1.10.640.10 | |
| Domain | Haem_peroxidase_animal | 2.53e-07 | 10 | 25 | 3 | IPR019791 | |
| Domain | An_peroxidase | 2.53e-07 | 10 | 25 | 3 | PF03098 | |
| Domain | ELM2 | 1.33e-04 | 13 | 25 | 2 | PF01448 | |
| Domain | ELM2 | 1.33e-04 | 13 | 25 | 2 | PS51156 | |
| Domain | ELM2_dom | 1.33e-04 | 13 | 25 | 2 | IPR000949 | |
| Domain | ELM2 | 1.33e-04 | 13 | 25 | 2 | SM01189 | |
| Domain | Olfact_rcpt | 1.51e-04 | 393 | 25 | 5 | IPR000725 | |
| Domain | GPCR_Rhodpsn_7TM | 2.06e-04 | 670 | 25 | 6 | IPR017452 | |
| Domain | 7tm_1 | 2.18e-04 | 677 | 25 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.32e-04 | 685 | 25 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.43e-04 | 691 | 25 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.45e-04 | 692 | 25 | 6 | IPR000276 | |
| Domain | SANT_dom | 5.48e-04 | 26 | 25 | 2 | IPR017884 | |
| Domain | SANT | 6.36e-04 | 28 | 25 | 2 | PS51293 | |
| Domain | Myb_DNA-binding | 9.96e-04 | 35 | 25 | 2 | PF00249 | |
| Domain | MYB_LIKE | 1.17e-03 | 38 | 25 | 2 | PS50090 | |
| Domain | SANT | 2.03e-03 | 50 | 25 | 2 | SM00717 | |
| Domain | SANT/Myb | 2.19e-03 | 52 | 25 | 2 | IPR001005 | |
| Domain | - | 6.83e-03 | 93 | 25 | 2 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 7.71e-03 | 99 | 25 | 2 | IPR011029 | |
| Domain | 7TM_GPCR_Srsx | 9.77e-03 | 112 | 25 | 2 | SM01381 | |
| Domain | EGF | 1.22e-02 | 126 | 25 | 2 | PF00008 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 1.54e-05 | 5 | 18 | 2 | M22024 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 4.29e-05 | 8 | 18 | 2 | MM1547 | |
| Pathway | WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS | 5.51e-05 | 9 | 18 | 2 | M48307 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 9.93e-05 | 389 | 18 | 5 | M14091 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.38e-04 | 417 | 18 | 5 | M4072 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.60e-04 | 15 | 18 | 2 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.60e-04 | 15 | 18 | 2 | M27149 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 2.60e-04 | 19 | 18 | 2 | M39473 | |
| Pathway | WP_ASPIRIN_AND_MIRNAS | 2.60e-04 | 19 | 18 | 2 | M48319 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 2.89e-04 | 20 | 18 | 2 | MM1529 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 3.50e-04 | 22 | 18 | 2 | MM15961 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 3.50e-04 | 22 | 18 | 2 | M22003 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 3.83e-04 | 23 | 18 | 2 | M39382 | |
| Pathway | WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122 | 7.01e-04 | 31 | 18 | 2 | M42531 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 7.01e-04 | 31 | 18 | 2 | M39851 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 7.47e-04 | 32 | 18 | 2 | MM15850 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 7.94e-04 | 33 | 18 | 2 | MM15918 | |
| Pathway | WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321 | 8.43e-04 | 34 | 18 | 2 | M48061 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 9.65e-04 | 636 | 18 | 5 | M41834 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 1.48e-03 | 45 | 18 | 2 | M39355 | |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 2.36e-03 | 57 | 18 | 2 | M48332 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 2.44e-03 | 58 | 18 | 2 | M5410 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.52e-03 | 59 | 18 | 2 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.70e-03 | 61 | 18 | 2 | MM14861 | |
| Pathway | WP_SELENIUM_MICRONUTRIENT_NETWORK | 5.28e-03 | 86 | 18 | 2 | M39385 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 6.02e-03 | 92 | 18 | 2 | MM15823 | |
| Pubmed | Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH. | 4.96e-07 | 2 | 25 | 2 | 12411530 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 9665805 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 9256365 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 9362331 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8424659 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8882280 | ||
| Pubmed | Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice. | 4.96e-07 | 2 | 25 | 2 | 16815697 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12665651 | ||
| Pubmed | An imbalance of COX level is not related to placental abruption. | 4.96e-07 | 2 | 25 | 2 | 21561892 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17643885 | ||
| Pubmed | Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues. | 4.96e-07 | 2 | 25 | 2 | 19769727 | |
| Pubmed | Peroxide-induced radical formation at TYR385 and TYR504 in human PGHS-1. | 4.96e-07 | 2 | 25 | 2 | 19433337 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27845343 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12045254 | ||
| Pubmed | Ocular prostaglandin production and morphology in mice lacking a single isoform of cyclooxygenase. | 4.96e-07 | 2 | 25 | 2 | 19767186 | |
| Pubmed | Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. | 4.96e-07 | 2 | 25 | 2 | 10487525 | |
| Pubmed | Multiple female reproductive failures in cyclooxygenase 2-deficient mice. | 4.96e-07 | 2 | 25 | 2 | 9346237 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18459455 | ||
| Pubmed | Placental tissue cyclo-oxygenase 1 and 2 in pre-eclamptic and normal pregnancy. | 4.96e-07 | 2 | 25 | 2 | 16930602 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23742950 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20720307 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19887674 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18657230 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27401285 | ||
| Pubmed | Cyclo-oxygenase 2 function is essential for bone fracture healing. | 4.96e-07 | 2 | 25 | 2 | 12054171 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 15190260 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12958020 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19205707 | ||
| Pubmed | Genetic Variants in Cyclooxygenase-2 Contribute to Post-treatment Pain among Endodontic Patients. | 4.96e-07 | 2 | 25 | 2 | 26081267 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22982857 | ||
| Pubmed | Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality. | 4.96e-07 | 2 | 25 | 2 | 17110378 | |
| Pubmed | Distinct expression of cyclooxygenase-1 and -2 in the human thymus. | 4.96e-07 | 2 | 25 | 2 | 11981837 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18838483 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8071353 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 29676940 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10944235 | ||
| Pubmed | Variation in cyclooxygenase expression levels within the colorectum. | 4.96e-07 | 2 | 25 | 2 | 12720297 | |
| Pubmed | Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. | 4.96e-07 | 2 | 25 | 2 | 8181472 | |
| Pubmed | Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses. | 4.96e-07 | 2 | 25 | 2 | 16081878 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 1380156 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 11694451 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12922938 | ||
| Pubmed | Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. | 4.96e-07 | 2 | 25 | 2 | 12183660 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 11416042 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10216176 | ||
| Pubmed | Coupling between cyclooxygenases and terminal prostanoid synthases. | 4.96e-07 | 2 | 25 | 2 | 16140261 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27386631 | ||
| Pubmed | Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. | 4.96e-07 | 2 | 25 | 2 | 12163371 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 15263079 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10449516 | ||
| Pubmed | Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. | 4.96e-07 | 2 | 25 | 2 | 12093889 | |
| Pubmed | Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. | 4.96e-07 | 2 | 25 | 2 | 16732282 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 11832369 | ||
| Pubmed | Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes. | 4.96e-07 | 2 | 25 | 2 | 17130490 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 31510878 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16323955 | ||
| Pubmed | Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. | 4.96e-07 | 2 | 25 | 2 | 7510883 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17495879 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8994299 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 31735164 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 1536575 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16787416 | ||
| Pubmed | Both constitutive and inducible prostaglandin H synthase affect dermal wound healing in mice. | 4.96e-07 | 2 | 25 | 2 | 12118094 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19523994 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23850620 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12189249 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 9156514 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17982098 | ||
| Pubmed | Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions. | 4.96e-07 | 2 | 25 | 2 | 29180445 | |
| Pubmed | Cyclooxygenase regulates angiogenesis induced by colon cancer cells. | 4.96e-07 | 2 | 25 | 2 | 9630216 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10841517 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17264103 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17266762 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19060633 | ||
| Pubmed | The COX-2 pathway is essential during early stages of skeletal muscle regeneration. | 4.96e-07 | 2 | 25 | 2 | 15084473 | |
| Pubmed | Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. | 4.96e-07 | 2 | 25 | 2 | 11489266 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23668350 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 2109618 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17631383 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16787386 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 15720413 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19416639 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18997734 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25645360 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12055598 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17624243 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16518767 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25149102 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 15504548 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8070358 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17641673 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16678543 | ||
| Pubmed | Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. | 4.96e-07 | 2 | 25 | 2 | 12576525 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 14625295 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19723114 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22972377 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25164664 | ||
| Pubmed | Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells. | 4.96e-07 | 2 | 25 | 2 | 9463402 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10512676 | ||
| Pubmed | Expression of cyclooxygenase-1 and cyclooxygenase-2 in normal and pathological human oral mucosa. | 4.96e-07 | 2 | 25 | 2 | 21478098 | |
| Interaction | PTGIS interactions | 2.16e-05 | 7 | 21 | 2 | int:PTGIS | |
| Cytoband | 11p15.4 | 7.39e-08 | 200 | 25 | 5 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 4.86e-07 | 564 | 25 | 6 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 2.54e-03 | 137 | 25 | 2 | chr1p35 | |
| GeneFamily | Olfactory receptors, family 52 | 7.16e-10 | 49 | 17 | 5 | 165 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.11e-03 | 53 | 17 | 2 | 532 | |
| Coexpression | GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 3.10e-05 | 200 | 24 | 4 | M310 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 5.27e-05 | 12 | 24 | 2 | M47983 | |
| Computational | Neighborhood of MMP1 | 6.56e-04 | 32 | 13 | 2 | GNF2_MMP1 | |
| Computational | Neighborhood of PTX3 | 8.31e-04 | 36 | 13 | 2 | GNF2_PTX3 | |
| Computational | Neighborhood of BAG5 | 9.26e-04 | 38 | 13 | 2 | GCM_BAG5 | |
| Computational | Genes in the cancer module 70. | 1.19e-03 | 43 | 13 | 2 | MODULE_70 | |
| Drug | pravadoline | 9.78e-08 | 9 | 25 | 3 | CID000056463 | |
| Drug | Tolmetin | 1.16e-06 | 2 | 25 | 2 | DB00500 | |
| Drug | Piroxicam | 1.16e-06 | 2 | 25 | 2 | DB00554 | |
| Drug | Ibuprofen | 1.16e-06 | 2 | 25 | 2 | DB01050 | |
| Drug | Lornoxicam | 1.16e-06 | 2 | 25 | 2 | DB06725 | |
| Drug | N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide | 1.16e-06 | 2 | 25 | 2 | ctd:C468797 | |
| Drug | Fenoprofen | 1.16e-06 | 2 | 25 | 2 | DB00573 | |
| Drug | Ketoprofen | 1.16e-06 | 2 | 25 | 2 | DB01009 | |
| Drug | Tenoxicam | 1.16e-06 | 2 | 25 | 2 | DB00469 | |
| Drug | Ketorolac | 1.16e-06 | 2 | 25 | 2 | DB00465 | |
| Drug | Nabumetone | 1.16e-06 | 2 | 25 | 2 | DB00461 | |
| Drug | AC1O5RN5 | 1.16e-06 | 2 | 25 | 2 | CID006439421 | |
| Drug | Tiaprofenic acid | 1.16e-06 | 2 | 25 | 2 | DB01600 | |
| Drug | Acetaminophen | 1.16e-06 | 2 | 25 | 2 | DB00316 | |
| Drug | SC 299 | 1.16e-06 | 2 | 25 | 2 | ctd:C409370 | |
| Drug | flosulide | 1.16e-06 | 2 | 25 | 2 | ctd:C059178 | |
| Drug | 2-methoxybenzoic acid | 1.16e-06 | 2 | 25 | 2 | ctd:C081914 | |
| Drug | Oxaprozin | 1.16e-06 | 2 | 25 | 2 | DB00991 | |
| Drug | Antrafenine | 1.16e-06 | 2 | 25 | 2 | DB01419 | |
| Drug | Trisalicylate-choline | 1.16e-06 | 2 | 25 | 2 | DB01401 | |
| Drug | Bromfenac | 1.16e-06 | 2 | 25 | 2 | DB00963 | |
| Drug | Antipyrine | 1.16e-06 | 2 | 25 | 2 | DB01435 | |
| Drug | gamma-Homolinolenic acid | 1.16e-06 | 2 | 25 | 2 | DB00154 | |
| Drug | Suprofen | 1.16e-06 | 2 | 25 | 2 | DB00870 | |
| Drug | Diflunisal | 1.16e-06 | 2 | 25 | 2 | DB00861 | |
| Drug | cimicoxib | 1.16e-06 | 2 | 25 | 2 | CID000213053 | |
| Drug | Carprofen | 1.16e-06 | 2 | 25 | 2 | DB00821 | |
| Drug | Meloxicam | 1.16e-06 | 2 | 25 | 2 | DB00814 | |
| Drug | Salsalate | 1.16e-06 | 2 | 25 | 2 | DB01399 | |
| Drug | Salicylate-sodium | 1.16e-06 | 2 | 25 | 2 | DB01398 | |
| Drug | Magnesium salicylate | 1.16e-06 | 2 | 25 | 2 | DB01397 | |
| Drug | Naproxen | 1.16e-06 | 2 | 25 | 2 | DB00788 | |
| Drug | Mefenamic acid | 1.16e-06 | 2 | 25 | 2 | DB00784 | |
| Drug | Maleimides | 1.16e-06 | 2 | 25 | 2 | ctd:D008301 | |
| Drug | Flurbiprofen | 1.16e-06 | 2 | 25 | 2 | DB00712 | |
| Drug | Bismuth Subsalicylate | 1.16e-06 | 2 | 25 | 2 | DB01294 | |
| Drug | Lumiracoxib | 1.16e-06 | 2 | 25 | 2 | DB01283 | |
| Drug | MDL 035 | 1.16e-06 | 2 | 25 | 2 | CID000053454 | |
| Drug | tricin | 1.16e-06 | 2 | 25 | 2 | ctd:C017769 | |
| Drug | Nepafenac | 1.16e-06 | 2 | 25 | 2 | DB06802 | |
| Drug | Pyrazoles | 1.32e-06 | 20 | 25 | 3 | ctd:D011720 | |
| Drug | 5,8,11-eicosatrienoic acid | 1.78e-06 | 22 | 25 | 3 | CID000004028 | |
| Drug | 17-hydroxy-ent-kaur-15-en-19-oic acid | 3.47e-06 | 3 | 25 | 2 | CID000169654 | |
| Drug | firocoxib | 3.47e-06 | 3 | 25 | 2 | CID000208910 | |
| Drug | itazigrel | 3.47e-06 | 3 | 25 | 2 | CID000051087 | |
| Drug | Meclofenamic acid | 3.47e-06 | 3 | 25 | 2 | DB00939 | |
| Drug | Acetylsalicylic acid | 3.47e-06 | 3 | 25 | 2 | DB00945 | |
| Drug | Salicyclic acid | 3.47e-06 | 3 | 25 | 2 | DB00936 | |
| Drug | malabaricone C | 3.47e-06 | 3 | 25 | 2 | ctd:C071787 | |
| Drug | malabaricone B | 3.47e-06 | 3 | 25 | 2 | ctd:C071788 | |
| Drug | Phenylbutazone | 3.47e-06 | 3 | 25 | 2 | DB00812 | |
| Drug | AHR-10037 | 3.47e-06 | 3 | 25 | 2 | CID000132843 | |
| Drug | Etodolac | 3.47e-06 | 3 | 25 | 2 | DB00749 | |
| Drug | nesodine | 3.47e-06 | 3 | 25 | 2 | CID006475455 | |
| Drug | 2-propionyloxybenzoic acid | 3.47e-06 | 3 | 25 | 2 | CID000095938 | |
| Drug | 1a, 1b-dihomo-PGF2 | 3.47e-06 | 3 | 25 | 2 | CID006443812 | |
| Drug | 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone | 6.94e-06 | 4 | 25 | 2 | ctd:C106876 | |
| Drug | Balsalazide | 6.94e-06 | 4 | 25 | 2 | DB01014 | |
| Drug | 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone | 6.94e-06 | 4 | 25 | 2 | CID000134996 | |
| Drug | anolignan B | 6.94e-06 | 4 | 25 | 2 | CID000072388 | |
| Drug | Flufenamic Acid | 6.94e-06 | 4 | 25 | 2 | DB02266 | |
| Drug | oleanolic aldehyde | 6.94e-06 | 4 | 25 | 2 | CID005320280 | |
| Drug | AI-122 | 6.94e-06 | 4 | 25 | 2 | CID000134058 | |
| Drug | 12-HPETE | 6.94e-06 | 4 | 25 | 2 | ctd:C021201 | |
| Drug | NSC-327431 | 6.94e-06 | 4 | 25 | 2 | CID000362637 | |
| Drug | triacontanol | 6.94e-06 | 4 | 25 | 2 | CID000068972 | |
| Drug | prostaglandin G2 | 6.94e-06 | 4 | 25 | 2 | ctd:C038291 | |
| Drug | 2-chloropyridine | 6.94e-06 | 4 | 25 | 2 | CID000007977 | |
| Drug | prantschimgin | 6.94e-06 | 4 | 25 | 2 | CID000025785 | |
| Drug | Resveratrol | 6.94e-06 | 4 | 25 | 2 | DB02709 | |
| Drug | Niflumic Acid | 6.94e-06 | 4 | 25 | 2 | DB04552 | |
| Drug | C9H7BrO4 | 6.94e-06 | 4 | 25 | 2 | CID000073922 | |
| Drug | sulfanilide | 6.94e-06 | 4 | 25 | 2 | CID000068517 | |
| Drug | 8beta-prostane | 6.94e-06 | 4 | 25 | 2 | CID000107873 | |
| Drug | SC57666 | 6.94e-06 | 4 | 25 | 2 | CID000443373 | |
| Drug | glyceryl 2-arachidonate | 7.48e-06 | 35 | 25 | 3 | ctd:C094503 | |
| Drug | REV 5901 | 1.04e-05 | 39 | 25 | 3 | CID000005059 | |
| Drug | 1-octanoyl-2-acetylglycerol | 1.16e-05 | 5 | 25 | 2 | CID000130710 | |
| Drug | sakuranin | 1.16e-05 | 5 | 25 | 2 | CID000073607 | |
| Drug | 4'-piperidinoacetophenone | 1.16e-05 | 5 | 25 | 2 | CID000082561 | |
| Drug | nictindole | 1.16e-05 | 5 | 25 | 2 | CID000065796 | |
| Drug | Indomethacin | 1.16e-05 | 5 | 25 | 2 | DB00328 | |
| Drug | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 1.16e-05 | 5 | 25 | 2 | ctd:C478738 | |
| Drug | fenflumizole | 1.16e-05 | 5 | 25 | 2 | CID000068917 | |
| Drug | Flupenthixol | 1.16e-05 | 5 | 25 | 2 | ctd:D005475 | |
| Drug | 4-methylesculetin | 1.16e-05 | 5 | 25 | 2 | CID005319502 | |
| Drug | loxoprofen | 1.16e-05 | 5 | 25 | 2 | ctd:C040656 | |
| Drug | M 5011 | 1.16e-05 | 5 | 25 | 2 | CID000127523 | |
| Drug | dithymoquinone | 1.16e-05 | 5 | 25 | 2 | CID000398941 | |
| Drug | DuP 697 | 1.16e-05 | 5 | 25 | 2 | ctd:C064874 | |
| Drug | PGF-M | 1.16e-05 | 5 | 25 | 2 | CID003082337 | |
| Drug | Sulindac | 1.16e-05 | 5 | 25 | 2 | DB00605 | |
| Drug | 12-HPETE | 1.40e-05 | 43 | 25 | 3 | CID000001415 | |
| Drug | palmitoylethanolamide | 1.50e-05 | 44 | 25 | 3 | CID000004671 | |
| Drug | 15-hydroperoxy-PGE2 | 1.73e-05 | 6 | 25 | 2 | CID006444110 | |
| Drug | desproglumideproglumetacin | 1.73e-05 | 6 | 25 | 2 | CID000126678 | |
| Drug | proglumetacin | 1.73e-05 | 6 | 25 | 2 | CID000004921 | |
| Drug | 2,6-dimethoxyquinol | 1.73e-05 | 6 | 25 | 2 | CID000096038 | |
| Drug | KBT-3022 | 1.73e-05 | 6 | 25 | 2 | CID000065870 | |
| Drug | isolicoflavonol | 1.73e-05 | 6 | 25 | 2 | CID005318585 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 7.36e-10 | 57 | 23 | 5 | DOID:10652 (implicated_via_orthology) | |
| Disease | gliosarcoma (biomarker_via_orthology) | 5.81e-07 | 2 | 23 | 2 | DOID:3071 (biomarker_via_orthology) | |
| Disease | glioblastoma (biomarker_via_orthology) | 3.48e-06 | 4 | 23 | 2 | DOID:3068 (biomarker_via_orthology) | |
| Disease | Intestinal Polyps | 5.80e-06 | 5 | 23 | 2 | C0021846 | |
| Disease | ulcerative colitis (implicated_via_orthology) | 1.22e-05 | 7 | 23 | 2 | DOID:8577 (implicated_via_orthology) | |
| Disease | Creutzfeldt-Jakob disease (is_marker_for) | 2.61e-05 | 10 | 23 | 2 | DOID:11949 (is_marker_for) | |
| Disease | Asthma, Occupational | 2.61e-05 | 10 | 23 | 2 | C0264423 | |
| Disease | Mechanical Allodynia | 3.78e-05 | 84 | 23 | 3 | C2936719 | |
| Disease | Hyperalgesia | 3.78e-05 | 84 | 23 | 3 | C0020429 | |
| Disease | Allodynia | 3.78e-05 | 84 | 23 | 3 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 3.78e-05 | 84 | 23 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.78e-05 | 84 | 23 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.78e-05 | 84 | 23 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 3.78e-05 | 84 | 23 | 3 | C0751213 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 5.26e-05 | 14 | 23 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Gastric ulcer | 8.82e-05 | 18 | 23 | 2 | C0038358 | |
| Disease | bipolar disorder (is_marker_for) | 9.86e-05 | 19 | 23 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Marijuana Abuse | 2.49e-04 | 30 | 23 | 2 | C0024809 | |
| Disease | Huntington's disease (implicated_via_orthology) | 2.84e-04 | 32 | 23 | 2 | DOID:12858 (implicated_via_orthology) | |
| Disease | Kidney Neoplasm | 4.45e-04 | 40 | 23 | 2 | C0022665 | |
| Disease | Depression, Neurotic | 4.68e-04 | 41 | 23 | 2 | C0282126 | |
| Disease | Melancholia | 4.68e-04 | 41 | 23 | 2 | C0025193 | |
| Disease | Depressive Syndrome | 4.91e-04 | 42 | 23 | 2 | C0086133 | |
| Disease | Schizophrenia | 5.10e-04 | 883 | 23 | 5 | C0036341 | |
| Disease | glioblastoma (is_marker_for) | 5.39e-04 | 44 | 23 | 2 | DOID:3068 (is_marker_for) | |
| Disease | Malignant neoplasm of kidney | 5.64e-04 | 45 | 23 | 2 | C0740457 | |
| Disease | Endogenous depression | 5.89e-04 | 46 | 23 | 2 | C0011573 | |
| Disease | Kidney Failure, Chronic | 6.41e-04 | 48 | 23 | 2 | C0022661 | |
| Disease | response to TNF antagonist | 8.11e-04 | 54 | 23 | 2 | EFO_0004653 | |
| Disease | Acute Cerebrovascular Accidents | 8.11e-04 | 54 | 23 | 2 | C0751956 | |
| Disease | Atherogenesis | 9.68e-04 | 59 | 23 | 2 | C1563937 | |
| Disease | Pancreatitis | 9.68e-04 | 59 | 23 | 2 | C0030305 | |
| Disease | Atherosclerosis | 9.68e-04 | 59 | 23 | 2 | C0004153 | |
| Disease | Mental Depression | 9.83e-04 | 254 | 23 | 3 | C0011570 | |
| Disease | Cerebrovascular accident | 1.07e-03 | 62 | 23 | 2 | C0038454 | |
| Disease | Depressive disorder | 1.42e-03 | 289 | 23 | 3 | C0011581 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFFNVSDGSHIFTFH | 461 | Q6UXG8 | |
| TSHGKGVFFTFHTFH | 956 | Q7Z408 | |
| VFAFTNFSSSHDHFR | 2011 | Q6UVK1 | |
| VFACSFVNFHVFHGV | 86 | P34972 | |
| VLFEQAFSFHGKTFH | 201 | Q9UKL0 | |
| LFEQAFSFHGKSFHR | 96 | Q9P2K3 | |
| GQHHIFSFFAFKENR | 1396 | Q01484 | |
| PAFFSFFSHRFGEHI | 256 | Q8NGI2 | |
| VSFDHAPHNFGFRFF | 216 | Q8NFM7 | |
| IFFGDEQHGFVFSHT | 141 | Q8NFG4 | |
| FYSFRHISFQDFFHA | 461 | Q86W26 | |
| FLANFFSEFPCHFLH | 1626 | Q6ZU64 | |
| LLAFFSFFTHRFGSH | 256 | Q9UKL2 | |
| LLAFFSFFTHRFGSH | 256 | Q9H2C5 | |
| FFAQHFTHQFFKTDH | 186 | P35354 | |
| AAFFTFFTHRFVGHN | 256 | Q8NGI0 | |
| MFAFFAQHFTHQFFK | 196 | P23219 | |
| FFTPAFFSFLTHRFG | 256 | Q6IFG1 | |
| FVIHSGFFFDNNSHD | 321 | Q86TU7 | |
| IGVHFVFDTAFSRHF | 146 | Q9H6Q4 | |
| IFNAFATAAFRFGHT | 1061 | Q92626 | |
| HAFHTCGVFSTLAFF | 56 | P56557 | |
| FFQHRIHWFSIFNSF | 216 | Q9HD45 | |
| QFHFAFLFLTHFNTH | 236 | Q14656 | |
| AIPSDVSHFRFHFFF | 401 | Q9GZU3 |